Symptoms early ovarian cancer early detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Ovary Epithelial Cells Prostate Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases56

Ovarian Neoplasms Uterine Cervical Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Prostatic Neoplasms Cystadenocarcinoma, Serous Lung Neoplasms Neoplasms Neoplasm Invasiveness Carcinoma Neoplasm Metastasis Colonic Neoplasms Stomach Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Disease Progression Neoplasm Recurrence, Local Colorectal Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Endometrial Neoplasms Peritoneal Neoplasms Carcinoma, Endometrioid Urinary Bladder Neoplasms Adenocarcinoma Carcinoma, Non-Small-Cell Lung Ascites Cell Transformation, Neoplastic Precancerous Conditions Mouth Neoplasms Rectal Neoplasms Genital Neoplasms, Female Esophageal Neoplasms Liver Neoplasms Cystadenocarcinoma Neovascularization, Pathologic Skin Neoplasms Neoplastic Syndromes, Hereditary Head and Neck Neoplasms Fallopian Tube Neoplasms Neoplasms, Second Primary Disease Models, Animal Bone Neoplasms Melanoma Gastrointestinal Neoplasms Neoplasms, Multiple Primary Neoplasms, Radiation-Induced Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Hormone-Dependent Carcinoma, Small Cell Carcinoma in Situ Hereditary Breast and Ovarian Cancer Syndrome Fatigue Pharyngeal Neoplasms Neoplastic Cells, Circulating

Chemicals and Drugs46

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel RNA, Messenger Cancer Vaccines BRCA2 Protein DNA, Neoplasm BRCA1 Protein Antineoplastic Agents, Phytogenic Antigens, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Epididymal Secretory Proteins Receptor, erbB-2 Receptors, Estrogen Tumor Suppressor Protein p53 Antibodies, Monoclonal Carboplatin MicroRNAs DNA Primers Receptors, Progesterone Tumor Suppressor Proteins Tamoxifen Biological Markers RNA, Neoplasm Receptor, Epidermal Growth Factor Fluorouracil Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents, Hormonal DNA-Binding Proteins Taxoids Transcription Factors Proto-Oncogene Proteins Platinum Anticarcinogenic Agents Nuclear Proteins Deoxycytidine Carcinoembryonic Antigen Proto-Oncogene Proteins c-akt Organoplatinum Compounds Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Antibiotics, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Early Diagnosis Sensitivity and Specificity Prognosis Neoplasm Staging Prospective Studies Polymerase Chain Reaction Risk Factors Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Follow-Up Studies Reproducibility of Results Survival Rate Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Xenograft Model Antitumor Assays Risk Predictive Value of Tests Questionnaires Risk Assessment Treatment Outcome Blotting, Western Disease-Free Survival Registries Odds Ratio Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Combined Modality Therapy Immunohistochemistry Genetic Testing Incidence Multivariate Analysis Enzyme-Linked Immunosorbent Assay ROC Curve Kaplan-Meier Estimate Logistic Models Transplantation, Heterologous Case-Control Studies Limit of Detection Immunoenzyme Techniques Cohort Studies Chemotherapy, Adjuvant Tumor Burden Clinical Trials as Topic Drug Screening Assays, Antitumor Tissue Array Analysis Neoplasm Grading Prevalence Biopsy DNA Mutational Analysis SEER Program Confidence Intervals Flow Cytometry Transfection Models, Biological Tomography, X-Ray Computed Drug Administration Schedule Molecular Targeted Therapy Breast Self-Examination False Positive Reactions Disease Models, Animal Real-Time Polymerase Chain Reaction Cross-Sectional Studies Pilot Projects Gene Knockdown Techniques Symptom Assessment Immunoassay Cluster Analysis Radiotherapy Feasibility Studies Regression Analysis Magnetic Resonance Imaging Positron-Emission Tomography Colonoscopy Palliative Care Severity of Illness Index Evaluation Studies as Topic

Psychiatry and Psychology3

Smoking Breast Self-Examination Depression

Phenomena and Processes45

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Mutation Genes, BRCA2 Risk Time Factors DNA Methylation Odds Ratio Germ-Line Mutation Genotype Cell Proliferation Apoptosis Cell Survival Base Sequence Dose-Response Relationship, Drug Down-Regulation Cell Movement Promoter Regions, Genetic Genes, Tumor Suppressor Cell Division Polymorphism, Genetic Up-Regulation Algorithms Cell Growth Processes Cell Cycle Signal Transduction Transfection Gene Silencing RNA Interference Phenotype Genes, Neoplasm Gene Expression Heterozygote Alleles Genes, p53 Postmenopause Diet Drug Synergism Menopause Epigenesis, Genetic Gene Amplification Phosphorylation

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Proteomics Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Questionnaires Registries Incidence Base Sequence Molecular Sequence Data Prevalence Algorithms SEER Program

Named Groups3

Medically Uninsured Survivors European Continental Ancestry Group

Health Care44

Mass Screening Sensitivity and Specificity Prospective Studies Risk Factors Survival Analysis Retrospective Studies Follow-Up Studies Reproducibility of Results Survival Rate Risk Predictive Value of Tests Questionnaires Risk Assessment Age Factors Treatment Outcome Disease-Free Survival Registries Odds Ratio National Cancer Institute (U.S.)Genetic Testing Incidence Multivariate Analysis ROC Curve Kaplan-Meier Estimate Logistic Models Case-Control Studies Limit of Detection Cohort Studies Clinical Trials as Topic Prevalence SEER Program Confidence Intervals American Cancer Society Cross-Sectional Studies Pilot Projects Cluster Analysis Age Distribution Sex Factors Genetic Counseling Feasibility Studies Regression Analysis Palliative Care Severity of Illness Index Evaluation Studies as Topic

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Detection of Cancer Mammography Uterine Cervical Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Vaginal Smears United States Neoplasms, Glandular and Epithelial Early Diagnosis Sensitivity and Specificity CA-125 Antigen Tumor Markers, Biological Cell Line, Tumor Prostatic Neoplasms Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Lung Neoplasms Genes, BRCA1 Prognosis Neoplasms Neoplasm Invasiveness Carcinoma Mice, Nude Neoplasm Staging Antineoplastic Agents Neoplasm Metastasis Neoplasm Proteins Drug Resistance, Neoplasm Colonic Neoplasms Stomach Neoplasms Prospective Studies Polymerase Chain Reaction Risk Factors Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Retrospective Studies Follow-Up Studies Pancreatic Neoplasms Reproducibility of Results Disease Progression Survival Rate Cisplatin Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Mutation Genes, BRCA2 Paclitaxel Xenograft Model Antitumor Assays Risk Predictive Value of Tests Questionnaires RNA, Messenger Neoplasm Recurrence, Local Cancer Vaccines Risk Assessment Age Factors Time Factors BRCA2 Protein Colorectal Neoplasms DNA, Neoplasm Carcinoma, Squamous Cell DNA Methylation BRCA1 Protein Adenocarcinoma, Clear Cell Treatment Outcome Adenocarcinoma, Mucinous Blotting, Western Disease-Free Survival Registries Endometrial Neoplasms Peritoneal Neoplasms Carcinoma, Endometrioid Odds Ratio Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Urinary Bladder Neoplasms Germ-Line Mutation Tumor Cells, Cultured Antineoplastic Agents, Phytogenic Genotype Adenocarcinoma Cell Proliferation Combined Modality Therapy Carcinoma, Non-Small-Cell Lung Antigens, Neoplasm Prostate-Specific Antigen National Cancer Institute (U.S.)Immunohistochemistry Genetic Testing Incidence RNA, Small Interfering Ascites Epididymal Secretory Proteins Apoptosis Multivariate Analysis Receptor, erbB-2 Survivors

No FAQ available that match "symptoms early ovarian cancer early detection of cancer"